MLTX
MoonLake Immunotherapeutics
NASDAQ: MLTX · HEALTHCARE · BIOTECHNOLOGY
$16.38
+1.68% today
Updated 2026-04-30
Market cap
$1.23B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.53
Dividend yield
—
52W range
$6 – $63
Volume
1.1M
MoonLake Immunotherapeutics (MLTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-6.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-27.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-3.9%
2026-02-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.92 | +6.0% | $18.22 | $17.51 | -3.9% |
| 2025-11-05 | $-1.10 | -25.2% | $10.13 | $10.29 | +1.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.98 | $-0.92 | +6.0% | — | — |
| 2025-09-30 | $-0.88 | $-1.10 | -25.2% | — | — |
| 2025-06-30 | $-0.72 | $-0.87 | -20.8% | — | — |
| 2025-03-31 | $-0.74 | $-0.63 | +14.3% | — | — |
| 2024-12-31 | $-0.59 | $-0.72 | -21.5% | $101850.00 | +416.0% |
| 2024-09-30 | $-0.44 | $-0.56 | -27.3% | — | — |
| 2024-06-30 | $-0.28 | $-0.39 | -39.3% | — | — |
| 2024-03-31 | $-0.19 | $-0.22 | -15.8% | $19738.00 | — |
| 2023-12-31 | $-0.23 | $-0.12 | +47.8% | $19738.00 | — |
| 2023-09-30 | $-0.23 | $-0.18 | +21.7% | — | — |
| 2023-06-30 | $-0.27 | $-0.23 | +14.8% | — | — |
| 2023-03-31 | $-0.31 | $-0.23 | +25.8% | — | — |
| 2022-12-31 | $-0.33 | $-0.31 | +6.1% | — | — |
Frequently asked questions
Has MoonLake Immunotherapeutics beaten earnings estimates?
MoonLake Immunotherapeutics has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -6.4% over the last 4 quarters.
How does MLTX stock react to earnings?
MLTX stock has moved an average of -1.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.